In conclusion, the present study’s results suggest that STAT4 is a valid prognostic indicator, and its high expression predicts lower survival and high levels of Tregs, its targeted intervention may be beneficial in treating AML patients. The gene discussed is STAT4; the disease is acute myeloid leukemia.